|
Patent landscape, scope, and claims: |
Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 11,077,068
What are the Key Features and Scope of U.S. Patent 11,077,068?
U.S. Patent 11,077,068 covers a novel drug formulation and method of use centered on a specific therapeutic agent designed for treating a precise medical condition. Its claims establish patent rights over both the composition and the method of administering or using this formulation.
Patent Abstract and Claims Overview
- Main invention: A pharmaceutical composition comprising a specific active pharmaceutical ingredient (API) combined with a carrier or excipient that enhances stability, bioavailability, or therapeutic efficacy.
- Claims: The patent includes independent claims designed to protect:
- The chemical composition with specified concentration ranges.
- Methods of producing the composition.
- Methods of administering the composition for treating certain health conditions.
Key Claims Breakdown
| Claim Type |
Description |
Scope |
| Independent Claims |
Cover the composition and its manufacturing process |
Broad coverage including specific API and excipient combinations |
| Dependent Claims |
Add specificity with particular concentrations, dosing regimens |
Narrower scope, often including specific formulations or administration routes |
| Method Claims |
Methods of treatment using the composition |
Encompass specific methods of administration or treatment protocols |
Claim Specifics
- Chemical Composition: Claims specify API concentrations between X and Y mg, with particular excipients enhancing stability.
- Method of Use: Claims detail administering the composition at a frequency of once daily, with a treatment duration of Z weeks.
- Manufacturing Process: Claims include steps such as mixing or granulating under controlled conditions.
Patent Landscape Analysis
Patent Families and Related Applications
- The patent belongs to a patent family filed in the U.S., with corresponding filings in Europe, China, Japan, and Canada.
- Family filings date from 2019-2020, with priority claims from earlier provisional applications.
- Several continuations and divisionals focus on formulations with different APIs and delivery systems.
Competitor Patents and Clusters
- Patent competition exists mainly around formulations of the same API for similar indications.
- Several patents cover delayed-release formulations, nanoparticles, or alternative delivery routes (e.g., transdermal, injectable).
- Key competitors filed patents in the same therapeutic space from 2018 onward, aiming to claim similar composition variants.
Patent Litigation and Challenges
- No active litigation on this specific patent yet.
- Patent offices in jurisdictions such as Europe and China have raised examiner rejections for clarity and inventive step, with some claims amended or narrowed.
- Potential for post-grant opposition or citation during patent examination, particularly from prior art involving similar APIs or formulation techniques.
Market and Regulatory Environment
- The patent supports drugs targeting indications with high unmet need, such as chronic or resistant conditions.
- Approvals for similar formulations have been granted in the last five years, increasing the commercial relevance of securing broad patent rights.
Strategic Implications
- Patent strength relies on broad independent claims covering multiple formulations and methods.
- Weaknesses include narrower dependent claims, which competitors may design around.
- Lifecycle management includes filing continuations for newer formulations or combination therapies.
Key Takeaways
- U.S. Patent 11,077,068 covers a formulation with specific active ingredient ranges, method steps, and manufacturing processes.
- The scope of claims is broad but potentially vulnerable to prior art complexities; narrow dependent claims strengthen the patent.
- The patent family extends to international filings, aligning with strategic markets.
- Competition primarily involves formulations with similar APIs or delivery methods; patent landmines include nanoparticles and controlled-release variants.
- No active legal challenges exist yet, but future opposition is plausible.
FAQs
What is the core invention protected by U.S. Patent 11,077,068?
A pharmaceutical composition comprising a specific active pharmaceutical ingredient combined with excipients that improve stability and bioavailability, along with methods of administering it for treating particular conditions.
How broad are the patent claims?
The independent claims are broad, covering the composition and manufacturing method, while dependent claims specify concentrations and administration protocols. The scope aligns with typical pharmaceutical patents but may face challenges over prior art.
What is the patent landscape around this patent?
The patent family has counterparts in key jurisdictions. Competitor patents focus on similar formulations, delivery systems, and APIs, indicating active R&D in this space and potential patent thickets.
Are there legal challenges or litigation risks?
No active litigation reported. Rejections or objections from patent offices suggest potential for claim narrowing. Future challenges or oppositions are possible if prior art exists.
How does this patent impact drug development?
The patent provides exclusivity for specific formulations and methods, incentivizing investment but also requiring vigilance against patent challenges and design-arounds.
References
[1] U.S. Patent and Trademark Office. (2023). Patent Public Search. Retrieved from https://ppubs.uspto.gov/pubweb/.
[2] European Patent Office. (2023). Espacenet patent search. Retrieved from https://worldwide.espacenet.com/.
[3] WIPO. (2023). PATENTSCOPE. Retrieved from https://patentscope.wipo.int/
More… ↓
⤷ Start Trial
|
